Pfizer has agreed to supply five million doses of its Covid-19 vaccine to Sri Lanka under a commercial agreement with the State Pharmaceuticals Corporation (SPC), a Minister said yesterday.
State Minister of Production, Supply and Regulation of Pharmaceuticals Prof. Channa Jayasumana told the payment arrangement for the dispatch of Pfizer vaccines would be worked out later.
He said the dose of Pfizer vaccine was smaller than others, and therefore separate syringes will have to be arranged for administering it to people in the country. Besides, he said Sri Lanka had placed orders for 13 million doses of Sputnik V vaccine manufactured in Russia. It is a commercial arrangement between the SPC and Gamaleya Research Institute of Russia. The Minister said the Russian authorities would start the delivery process of the stock in batches starting from the end of this month.
“They will send us the stock in batches during the last week of every month starting from April,†he said. Asked about the regulatory clearance for China’s Sinopharm vaccine, he said it would be given immediately after the World Health Organization (WHO) listed it for emergency use. China has already donated 600,000 doses of this vaccine to Sri Lanka. Commenting on the Covid-19 situation, he said the health authorities were bracing for a spike of the cases by the next week.
importing vehicles under three years old will increase auction values in Japan due to their…
In a move aimed at providing relief to the public, Lanka Sathosa has announced a…
To combat the current coconut shortage, Sri Lanka looks at importing coconut products from Indonesia,…
The government has allocated Rs. 80 million for the 77th Independence Day celebrations, Provincial Councils…
The candidates who contested the general elections in 2024 under the New Democratic Front (NDF)…
The Department of Wildlife Conservation has reported that wild elephant deaths in the country decreased…
View Comments
For India, Pfizer has offered a not-for-profit price for its vaccine for the Government immunization program. While Pfizer was the first company to seek emergency approval in India for its vaccine with BioNTech, its application was rejected because it had not conducted local trials in India.